Kate Flanders

发表论文 2 篇 · 总被引 94 次 · h-index 2

代表论文

• Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers (2021 · NEJM Evidence · 被引 78)
• VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma (2020 · Blood · 被引 16)